{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Talia M"],"funding":["Associazione Italiana per la Ricerca sul Cancro","Ministero della Salute"],"pagination":["164"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10337103"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["42(1)"],"pubmed_abstract":["Background
The receptor for advanced glycation-end products (RAGE) and its ligands have been implicated in obesity and associated inflammatory processes as well as in metabolic alterations like diabetes. In addition, RAGE-mediated signaling has been reported to contribute to the metastatic progression of breast cancer (BC), although mechanistic insights are still required. Here, we provide novel findings regarding the transcriptomic landscape and the molecular events through which RAGE may prompt aggressive features in estrogen receptor (ER)-positive BC.Methods
MCF7 and T47D BC cells stably overexpressing human RAGE were used as a model system to evaluate important changes like cell protrusions, migration, invasion and colony formation both in vitro through scanning electro"],"journal":["Journal of experimental & clinical cancer research : CR"],"pubmed_title":["The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells."],"pmcid":["PMC10337103"],"funding_grant_id":["RF-2013-02358446","21322","11904","21651","27386","RF-2019-12368937","23369","15538"],"pubmed_authors":["Spinelli A","De Rosis S","Filippelli G","Cirillo F","Rigiracciolo DC","Muglia L","Pece S","Nardo B","Brunelli E","Talia M","Belfiore A","Miglietta AM","Perrotta ID","Macirella R","Tosoni D","Scordamaglia D","De Rosa R","Davoli M","Zicarelli A","Lappano R","De Francesco EM","Maggiolini M"],"additional_accession":[]},"is_claimable":false,"name":"The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.","description":"Background
The receptor for advanced glycation-end products (RAGE) and its ligands have been implicated in obesity and associated inflammatory processes as well as in metabolic alterations like diabetes. In addition, RAGE-mediated signaling has been reported to contribute to the metastatic progression of breast cancer (BC), although mechanistic insights are still required. Here, we provide novel findings regarding the transcriptomic landscape and the molecular events through which RAGE may prompt aggressive features in estrogen receptor (ER)-positive BC.Methods
MCF7 and T47D BC cells stably overexpressing human RAGE were used as a model system to evaluate important changes like cell protrusions, migration, invasion and colony formation both in vitro through scanning electro","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jul","modification":"2025-04-22T21:14:02.835Z","creation":"2025-04-22T21:14:02.835Z"},"accession":"S-EPMC10337103","cross_references":{"pubmed":["37434266"],"doi":["10.1186/s13046-023-02747-5"]}}